Advanced Search
ZHANG Wenqing, WU Jing, XIE Di, SHI Xuecong, HU Hankun. Review of Development of Emerging Clinical Antitumor Therapeutics[J]. Cancer Research on Prevention and Treatment, 2022, 49(3): 176-181. DOI: 10.3971/j.issn.1000-8578.2022.21.1034
Citation: ZHANG Wenqing, WU Jing, XIE Di, SHI Xuecong, HU Hankun. Review of Development of Emerging Clinical Antitumor Therapeutics[J]. Cancer Research on Prevention and Treatment, 2022, 49(3): 176-181. DOI: 10.3971/j.issn.1000-8578.2022.21.1034

Review of Development of Emerging Clinical Antitumor Therapeutics

  • With the continuous progress of tumor treatment methods in recent years, more and more emerging antitumor drugs have been approved to market and put into clinical use. In addition, some treatments that are in clinical trials such as gene therapy are also continuously making new breakthroughs. In this review, we mainly give a brief introduction to the novel antineoplastic therapies that have been clinically used in recent years, as well as the ones with remarkable efficacy and are expected to be approved for marketing.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return